Darunavir is a potent second-generation HIV protease inhibitor used in the treatment of HIV-1 infection, typically administered in combination with ritonavir or cobicistat to improve its pharmacokinetic… Read more


![Chemical structure of [(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl-[(4-aminophenyl)sulfonyl]amino] propyl]carbamic Acid tert-Butyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F183004-94-6-1S2R-1-Benzyl-2-hydroxy-3-isobutyl-4-aminophenylsulfonylamino-propylcarbamic-Acid-tert-Butyl-Ester.png&w=3840&q=75)
![Chemical structure of [(1S,2R)-1-Benzyl-2-hydroxy-3-[isobutyl[(4-nitro-phenyl)sulfonyl)]amino]propyl]-carbamic Acid tert-Butyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F191226-98-9-1S2R-1-Benzyl-2-hydroxy-3-isobutyl4-nitro-phenylsulfonylaminopropyl-carbamic-Acid-tert-Butyl-Ester.png&w=3840&q=75)
amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic Acid Methyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1526916-57-3-1S2R-3-4-Aminophenylsulfonyl2-methylpropylamino-2-hydroxy-1-phenyl-methylpropylcarabamic-Acid-Methyl-Ester.png&w=3840&q=75)
amino]-2-hydroxy-1-(phenylmethyl)propyl]-Carbamic Acid Phenylmethyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F159005-61-5-1S2R-3-4-Aminophenylsulfonyl2-methylpropylamino-2-hydroxy-1-phenylmethylpropyl-Carbamic-Acid-Phenylmethyl-Ester.png&w=3840&q=75)
amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl- ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1S2R-3-4-Aminophenylsulfonyln-propylamino-2-hydroxy-1-phenylmethylpropylcarbamic-acid-3R3aS6aR-hexahydrofuro23-bfuran-3-yl-ester.png&w=3840&q=75)
![Chemical structure of [(3R,3aS,6aR)-Hydroxyhexahydrofuro[2,3-b]furanyl Succinimidyl Carbonate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F253265-97-3-3R3aS6aR-Hydroxyhexahydrofuro23-bfuranyl-Succinimidyl-Carbonate.png&w=3840&q=75)


































![Chemical structure of Hexahydrofuro[2,3-b]furan-3-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F109789-19-7-Hexahydrofuro23-bfuran-3-ol.png&w=3840&q=75)

Darunavir is a potent second-generation HIV protease inhibitor used in the treatment of HIV-1 infection, typically administered in combination with ritonavir or cobicistat to improve its pharmacokinetic profile. To ensure rigorous quality control and regulatory compliance, pharmaceutical laboratories utilize a comprehensive range of Darunavir reference standards, including synthetic intermediates, degradation products, and process-related impurities. These materials are essential for accurate impurity profiling, supporting the development and validation of sensitive analytical methods such as HPLC and LC-MS/MS. Furthermore, the inclusion of stable isotope labelled compounds provides critical internal standards for precise quantification in bioanalytical studies and pharmacopeial testing. By providing well-characterized benchmarks, these reference materials facilitate the identification and qualification of potential impurities, ensuring the safety, efficacy, and consistency of the final drug product throughout its development and manufacturing lifecycle.